Improving epilepsy diagnosis with advanced EEG analysis
EpiScalp: An EEG Analytics Solution to Improve Diagnosis of Epilepsy
['FUNDING_SBIR_2'] · NEUROLOGIC SOLUTIONS, INC. · NIH-10918584
This study is testing a new tool called EpiScalp that helps doctors more accurately diagnose epilepsy by analyzing short EEG recordings, making it easier for people who might have epilepsy to get the right treatment.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEUROLOGIC SOLUTIONS, INC. (nih funded) |
| Locations | 1 site (MCLEAN, UNITED STATES) |
| Trial ID | NIH-10918584 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the accuracy of epilepsy diagnosis through the development of EpiScalp, an innovative EEG analytics algorithm. By analyzing 10-20 minutes of EEG data, EpiScalp generates a risk score that helps identify epilepsy more reliably than traditional methods. The project aims to reduce misdiagnosis rates, which can lead to inappropriate treatments and significant health risks for patients. The approach combines advanced algorithms with clinical data to improve diagnostic outcomes for individuals suspected of having epilepsy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing seizures or those who have been referred for epilepsy evaluation.
Not a fit: Patients who have already received a definitive diagnosis of epilepsy and are stable on their current treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate epilepsy diagnoses, reducing unnecessary treatments and improving patient care.
How similar studies have performed: Previous research has shown promise in using advanced algorithms for EEG analysis, indicating potential for success in this novel approach.
Where this research is happening
MCLEAN, UNITED STATES
- NEUROLOGIC SOLUTIONS, INC. — MCLEAN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOTSHALK, ANDREW — NEUROLOGIC SOLUTIONS, INC.
- Study coordinator: GOTSHALK, ANDREW
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.